We are hereby submitting the notice of Annual General Meeting schedule to be held on Thursday, 27th August, 2026

Kilitch Drugs (India) Ltd. KI 1“ August, 2026 To, To, The Manager - Corporate Relationship The Manager - Corporate Compliance Dept. National Stock Exchange of India Ltd BSE Limited Exchange Plaza, Plot No.C-1, P. J. Towers, Dalal Street G Block, BKC, Bandra (E), Fort, Mumbai - 400 001 Mumbai 400 051 Scrip Code: BSE - 524500 Scrip Code: NSE - KILITCH Dear Sir, Sub: Notice of 34 Annual General Meeting of the Company We hereby would like to inform you that the 34" Annual General Meeting of the Company (AGM) will be held on Thursday, 27" August, 2026 at 9:00 am (IST) through Video Conferencing or Other Audio Visual Means. Pursuant to Regulations 30 and 34 of Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations 2015 (“Listing Regulations”), we are submitting herewith the Notice of 34 Annual General Meeting which is being sent to those members today whose e-mail addresses are registered with the Company/ Registrar & Share Transfer Agent / Depository Participant(s), in accordance with the MCA Circulars and SEBI Circulars. A member whose name 1s recorded in the Register of Members / Register of Beneficial Owners as on the Cut-Off Date ie. Thursday, 20" August, 2026 shall be entitled to avail the facility of remote e- voting / e-voting at the AGM. The remote e-voting facility shall commence on Monday, 24" August, 2026 at 9.00 AM (IST) and will end on Wednesday, 26" August, 2026 at 5.00 PM (IST). Detailed instructions pertaining to remote e-Voting and e-voting at the AGM are provided in Notice of the AGM. We request you to kindly take the same on record and acknowledge the receipt. Thanking you, For Kilitch Drugs (India) Limited Mukund Mehta Managing Director hIanas tacots .te (ih Gs)o k. ae Se INDIA 43485:2003 + WHO CERTIFIED Pharmacy one Wo Corporate office : 37/39, Ujagar Industrial Estate, W. T. Patil Marg, Deonar, Mumbai - 400 088. e Tel.: +91-22-6121 4100 « Fax : +91-22-6703 1658 Registered Office & Manufacturing unit : G-301/2, M.1.D.C., T.7.C. Industrial Area, Pawane Village, Navi Mumbai - 400 705. Maharashtra. « CIN: L24239MH1992PLC066718 « Tel.: +91-22-6299 6300 « Fax : +91-22-2768 0912 « E-mail : info@kilitch.com « Website : www.kilitch.com KILITCH DRUGS (INDIA) LIMITED Kilitch Drugs (India) Limited CIN: L24239MH1992PLC066718 Registered Office: C-301/2, M.I.D.C. TTC Industrial Area, Pawane Village, Navi Mumbai - 400 705. Tel: 022 61214100 Website: www.kilitch.com E-mail: pushpanyoupane(akilitch.com NOTICE OF THE ANNUAL GENERAL MEETING Notice is hereby given that the 34" Annual General SPECIAL BUSINESS: Meeting (“AGM”) of Kilitch Drugs (India) Limited will be held on Thursday, 27° August, 2026 at 9:00 am 3. Approve the payment of performance linked pay through Video Conferencing or Other Audio Visual (PLI) to executive directors means only to transacthte business: To consider and, if thought fit, to pass the following ORDINARY BUSINESS: Resolution as an Special Resolution “RESOLVED THAT, pursuant to the recommendation 1. Adoption of Financial Statement of the Nomination and Remuneration Committee and the approval of the Board, and in accordance with To receive, consider, approve and adopt the Audited Sections 196, 197, and other applicable provisions, if Standalone and Consolidated Financial Statements any, of the Companies Act, 2013 [including any of the Company for the year ended 31° March, 2026, statutory modification, amendment, or re-enactment together with the Report of the Board of Directors and thereof for the time being in force), read with the Auditors thereon; Companies [Appointment and Remuneration of Managerial Personnel) Rules, 2014, and Schedule V To consider and pass the following resolution as an to the said Acandt fu,rth er pursuaton tthe provisions Ordinary Resolution: of the Articles of Association of the Company, the consent of the Members be and is hereby accorded to “RESOLVED THAT the audited Standalone and the payment of Performance-Linked Incentive [PL] Consolidated financial statements of the Company to the Executive Directors, as more particularly set for the financial year ended 31° March, 2026 together out in the statement accompanying the notice with the Reports of the Board and Independent convening this meeting.” Auditors thereon and other Annexures and attachment therewith, as circulated to the members RESOLVED FURTHER THAT any one of the Directors be andare hereby received, considaepprroevedd ,an d and the Company Secretary be and is hereby adopted.” authorized, severally, to do all such acts, deeds, matters and things arising out of and incidental 2.Appointment of Mr. Mukund P. Mehta (DIN: thereto as may be deemed necessary, proper, 00147876) as a director who retires by rotation and expedient, or incidental to give effect to this being eligible, offers himself for re-appointment resolution including filing of necessary forms and returns with the Ministry of Corporate Affairs or To consider and if thought fit to pass the following submission of necessary documents with any other resolution as an Ordinary Resolution: concerned Authorities in connection with this resolution.” “RESOLVED THAT pursuant to the provisions of Section 152 read with Schedule V and other 4. to ratify the remuneration to Cost Auditor of the applicable provisions, if any, of the Companies Act, Company 2013, the approvoaf lth e members of the Company be and is hereby accorded to re-appoint Mr. Mukund P. To consider and, if thought fit, to pass the following Mehta (DIN: 00147876as)a Director, to the extent that Resolution as an Ordinary Resolution: he is requiretdo retire by rotation.” AGM NOTICE 2025-26 KILITCH DRUGS (INDIA) LIMITED “RESOLVED THAT pursuant to the provisions of Year ending 31° March, 2027, amountintgo Rs. 60,000 section 148 and other applicable provisions, if any, of (Rupees Sixty Thousand only) excluding taxes, be the Companies Act, 2013 and the Companies (Audit ratified. and Auditors} Rules, 2014 [including any statutory modification(s) or amendment(s) thereto or FURTHER RESOLVED that approval of the Company reenactment(s) thereof, for the time being in force] be accorded to the Board of Directors of the Company and pursuant to the recommendation of the Audit (including any Committee thereof) to do all such acts, Committee, the remuneration payable to M/s Arvind deeds, matters and things and to take all such steps Kumar & Co. Cost Accountants (Firm Registration as may be required in this connection including No. 000646), appointed by the Board of Directors of seeking all necessary approvals to give effect to this the Company as Cost Auditors to conduct the audit of Resolution and to settle any questions, difficulties or the cost records of the Company for the Financial doubts that may arise inthis regard.” By order of the Board For Kilitch Drugs (India) Limited Sd/- Pushpa Nyoupane Company Secretary Place: Mumbai Date: 28" July, 2026 Regd. Office: C-301/2, M.I.D.C. TTC Industrial Area, Pawane Village, Navi Mumbai - 400 705 KILITCH DRUGS (INDIA) LIMITED NOTES: inspection without any fee by the members from the date of circulation of this Notice up to the date of AGM, 1.The Ministry of Corporate Affairs (hereinafter i.e. 27° August, 2026. Members seeking to inspect referred to as the said “MCA”) permitted holding of such documents can send an email to the AGM through VC/OAVM, without physical pushpanyoupane@kilitch.com. presence of the Members at a common venue. Accordingly, in compliance with the MCA Circulars, 5. In compliance with the aforesaid MCA Circulars AGM of the Company is being held through VC/OAVM. and SEBI Circulars, Notice of the AGM along with the [General Circular Nos. 14/2020 dated April 8, 2020 Annual Report 2025-26 is being sent only through and 17/2020 dated 13” April, 2020, in relation to electronic mode to those Members whose email “Clarification on passing of ordinary and special addresses are registered with the Company resolutions by companies under the Co [Showing first 8,000 characters — download PDF for full document]